These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38677539)

  • 1. Inhibition of human UDP-glucuronosyltransferase enzyme by entrectinib: Implications for drug-drug interactions.
    Yin H; Wang Z; Lv X; Wang Z; Wang Y; Fan W; Li S; Jiang L; Cao J; Liu Y
    Chem Biol Interact; 2024 May; 395():111023. PubMed ID: 38677539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human UDP-glucuronosyltransferase enzyme by ripretinib: Implications for drug-drug interactions.
    Lv X; Wang Z; Wang Z; Yin H; Xia Y; Jiang L; Liu Y
    Toxicol Appl Pharmacol; 2023 May; 466():116490. PubMed ID: 36963523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human UDP-glucuronosyltransferase enzyme by Dabrafenib: Implications for drug-drug interactions.
    Yin H; Wang Z; Wang X; Lv X; Fan X; Yan M; Jia Y; Jiang L; Cao J; Liu Y
    Biomed Chromatogr; 2021 Nov; 35(11):e5205. PubMed ID: 34192355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-drug interaction potentials of tucatinib inhibition of human UDP-glucuronosyltransferases.
    Lv X; Wang Z; Wang Z; Yin H; Xia Y; Jiang L; Liu Y
    Chem Biol Interact; 2023 Aug; 381():110574. PubMed ID: 37263554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted screen for human UDP-glucuronosyltransferases inhibitors and the evaluation of potential drug-drug interactions with zafirlukast.
    Oda S; Fujiwara R; Kutsuno Y; Fukami T; Itoh T; Yokoi T; Nakajima M
    Drug Metab Dispos; 2015 Jun; 43(6):812-8. PubMed ID: 25834030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piceatannol exhibits potential food-drug interactions through the inhibition of human UDP-glucuronosyltransferase (UGT) in Vitro.
    Jiang L; Wang Z; Wang X; Wang S; Wang Z; Liu Y
    Toxicol In Vitro; 2020 Sep; 67():104890. PubMed ID: 32446839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cabozantinib Carries the Risk of Drug-Drug Interactions
    Wang Z; Jiang L; Wang X; Yin H; Wang Z; Lv X; Liu Y
    Curr Drug Metab; 2022; 23(11):912-919. PubMed ID: 36306450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human UDP-glucuronosyltransferase enzyme by belinostat: Implications for drug-drug interactions.
    Wang X; Wang Z; Wang Z; Chen X; Yin H; Jiang L; Cao J; Liu Y
    Toxicol Lett; 2021 Mar; 338():51-57. PubMed ID: 33290829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro inhibitory effects of selumetinib on activity of human UDP-glucuronosyltransferases and prediction of in vivo drug-drug interactions.
    Yin H; Lv X; Wang Z; Xiao S; Liang J; Sun J; Jiang L; Liu Y
    Toxicol In Vitro; 2024 Aug; 99():105863. PubMed ID: 38823552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-Drug Interaction Potentials of Tyrosine Kinase Inhibitors via Inhibition of UDP-Glucuronosyltransferases.
    Zhang N; Liu Y; Jeong H
    Sci Rep; 2015 Dec; 5():17778. PubMed ID: 26642944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro selective inhibition of human UDP-glucuronosyltransferase (UGT) 1A4 by finasteride, and prediction of in vivo drug-drug interactions.
    Lee SJ; Park JB; Kim D; Bae SH; Chin YW; Oh E; Bae SK
    Toxicol Lett; 2015 Jan; 232(2):458-65. PubMed ID: 25448279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the drug-drug interactions potential of ibrutinib and acalabrutinib via inhibition of UDP-glucuronosyltransferase.
    Wang X; Wang Z; Fan X; Yan M; Jiang L; Xia Y; Cao J; Liu Y
    Toxicol Appl Pharmacol; 2021 Aug; 424():115595. PubMed ID: 34038714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A broad-spectrum substrate for the human UDP-glucuronosyltransferases and its use for investigating glucuronidation inhibitors.
    Zhou QH; Qin WW; Finel M; He QQ; Tu DZ; Wang CR; Ge GB
    Int J Biol Macromol; 2021 Jun; 180():252-261. PubMed ID: 33741369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro Inhibition of Human UDP-Glucuronosyl-Transferase (UGT) Isoforms by Astaxanthin, β-Cryptoxanthin, Canthaxanthin, Lutein, and Zeaxanthin: Prediction of in Vivo Dietary Supplement-Drug Interactions.
    Zheng YF; Min JS; Kim D; Park JB; Choi SW; Lee ES; Na K; Bae SK
    Molecules; 2016 Aug; 21(8):. PubMed ID: 27529203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ciprofol is primarily glucuronidated by UGT1A9 and predicted not to cause drug-drug interactions with typical substrates of CYP1A2, CYP2B6, and CYP2C19.
    Hou L; Zhao Y; Zhao S; Zhang X; Yao X; Yang J; Wang Z; Chan ECY; Liu S
    Chem Biol Interact; 2024 Jan; 387():110811. PubMed ID: 37993078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chirality Influence of Zaltoprofen Towards UDP-Glucuronosyltransferases (UGTs) Inhibition Potential.
    Jia L; Hu C; Wang H; Liu Y; Liu X; Zhang YY; Li W; Wang LX; Cao YF; Fang ZZ
    Chirality; 2015 Jun; 27(6):359-63. PubMed ID: 25903196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phloretin exhibits potential food-drug interactions by inhibiting human UDP-glucuronosyltransferases in vitro.
    Chen J; Zhang H; Hu X; Xu M; Su Y; Zhang C; Yue Y; Zhang X; Wang X; Cui W; Zhao Z; Li X
    Toxicol In Vitro; 2022 Oct; 84():105447. PubMed ID: 35868516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pterostilbene supplements carry the risk of drug interaction via inhibition of UDP-glucuronosyltransferases (UGT) 1A9 enzymes.
    Jiang L; Zhang Z; Xia Y; Wang Z; Wang X; Wang S; Wang Z; Liu Y
    Toxicol Lett; 2020 Mar; 320():46-51. PubMed ID: 31812603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of aflatoxins on UDP-glucuronosyltransferases (UGTs).
    Du Z; Liu ZZ
    Toxicol In Vitro; 2023 Aug; 90():105612. PubMed ID: 37164184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the inhibition potential of parthenolide and micheliolide on various UDP-glucuronosyltransferase isoforms.
    Gao WF; Li YX; Zhang WH; Tao R; Yin TT; Wang YJ; Liu LN; Fu ZW; Li SN; Liu NR; Zhang H; Liu G; Zhao LZ; Zhang XP; Zhang CZ
    Xenobiotica; 2019 Oct; 49(10):1158-1163. PubMed ID: 30484368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.